This study is testing a Telehealth Serious Illness Care Program to help older patients with myeloid malignancies (like acute myeloid leukemia or myelodysplastic syndromes) and their families talk about important healthcare decisions. This program uses tools and training for doctors, and educational materials for patients. It's being compared to standard educational materials from the NCI. The study aims to see if this program improves how patients and doctors communicate, reduces patient anxiety, and helps complete advance directives (documents that state your healthcare wishes). You may be able to join if you are 60 or older, have a myeloid malignancy, are managed as an outpatient, and speak English. The study plans to enroll 207 participants, but its current status is unclear.

Study design

This is an interventional study comparing two approaches: a Telehealth Serious Illness Care Program and an education control. It plans to enroll 207 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Healthcare communication will be measured at Month 2.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.